(Q46975262)

27 December 2017

title

p53 mutation in hepatocellular carcinoma after aflatoxin exposure (English)

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

28 October 2022

main subject

hepatocellular carcinoma

1 reference

1

M. Ozturk

1 reference

PubMed ID

1682737

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682737

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

27 December 2017

30 November 1991

1 reference

National Center for Biotechnology Information

PubMed ID

1682737

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682737

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:014067369192236U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

https://api.elsevier.com/content/article/PII:014067369192236U?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

28 October 2022

1 reference

27 December 2017

volume

338

1 reference

27 December 2017

page(s)

1356-1359

1 reference

27 December 2017

issue

8779

1 reference

27 December 2017

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

p53 mutations in human cancers

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Aflatoxin exposure in human populations: measurements and relationship to cancer

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Estimates of the worldwide frequency of sixteen major cancers in 1980

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Epidemiology of primary liver cancer

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Changing incidence of hepatocellular carcinoma in Japan

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Hepatocellular carcinoma mutation

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Epidemiology, basic science, and the prevention of cancer: implications for the future

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Changing pattern of age-specific prevalence of hepatitis B surface antigen and corresponding antibody in Japan

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

Risk factors for hepatocellular carcinoma in Catalonia, Spain.

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92236-U

28 October 2022

Identifiers

1 reference

27 December 2017

PubMed ID

1682737

1 reference

27 December 2017